4//SEC Filing
Fairmount Funds Management LLC 4
Accession 0001104659-24-105106
CIK 0001690585other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 8:00 PM ET
Size
8.5 KB
Accession
0001104659-24-105106
Insider Transaction Report
Form 4
Fairmount Funds Management LLC
Director10% Owner
Transactions
- Other
Common Stock
2024-09-27−62,146→ 0 total(indirect: By LLC)
Holdings
- 2,700,691(indirect: By Fairmount Healthcare Fund II L.P.)
Common Stock
Kiselak Tomas
Director10% Owner
Transactions
- Other
Common Stock
2024-09-27−62,146→ 0 total(indirect: By LLC)
Holdings
- 2,700,691(indirect: By Fairmount Healthcare Fund II L.P.)
Common Stock
Footnotes (2)
- [F1]Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount SPV III, LLC ("Fairmount SPV") to its membership interest investors.
- [F2]Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. ("Fund II") and the Class A Member for Fairmount SPV. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
Documents
Issuer
Dianthus Therapeutics, Inc. /DE/
CIK 0001690585
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001802528
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 8:00 PM ET
- Size
- 8.5 KB